LATS2 and hepatocellular carcinoma: The lncRNA DDX11-AS1 suppresses the LATS2 protein via interacting with EZH2 and DNMT1 in HCC cells and may function as an oncogene, and the expression of DDX11-AS1 is correlated with a poor HCC prognosis (Li et al., 2019).